A peek inside the Huntington's brain: will functional imaging take us one step closer in solving the puzzle?

Experimental Neurology

Volumn 220, Issue 1, 2009, Pages 5-8

  Georgiou Karistianis, Nellie ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN BLOOD FLOW; BRAIN DYSFUNCTION; COGNITIVE DEFECT; DIFFUSION TENSOR IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL STATUS; HUMAN; HUNTINGTON CHOREA; IMAGE ANALYSIS; MOTOR DYSFUNCTION; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROIMAGING; NEUROPATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 70349745744     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.08.001     Document Type: Note

References (40)

1. Andrews T.C., Weeks R.A., Turjanski N., Gunn R.N., Watkins L.H.A., Sahakian B., Hodges J.R., Rosser A.E., Wood N.W., and Brooks D.J. Huntington's disease progression PET and clinical observations. Brain 122 (1999) 2353-2363
2. Antonini A., Leenders K.L., Spiegel R., Meier D., Vontobel P., WeigellWeber M., SanchezPernaute R., deYebenez J.G., Boesiger P., Weindl A., and Maguire R.P. Striatal glucose metabolism and dopamine D-2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain 119 (1996) 2085-2095
3. Aylward E.H., Sparks B.F., Field K.M., Yallapragada V., Shpritz B.D., Rosenblatt A., Brandt J., Gourley L.M., Liang K., Zhou H., Margolis R.L., and Ross C.A. Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 63 (2004) 66-72
4. Bartenstein P., Weindl A., Spiegel S., Boecker H., Wenzel R., CeballosBaumann A.O., Minoshima S., and Conrad B. Central motor processing in Huntington's disease-a PET study. Brain 120 (1997) 1553-1567
5. Bohanna I., Georgiou-Karistianis N., Hannan A.J., and Egan G.F. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease. Brain Res. Rev. 58 (2008) 209-225
6. Ciarmiello A., Cannella M., Lastoria S., Simonelli M., Frati L., Rubinsztein D.C., and Squitieri F. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J. Nucl. Med. 47 (2006) 215-222
7. Clark V.P., Lai S., and Deckel A.W. Altered functional MRI responses in Huntington's disease. NeuroReport 13 (2002) 703-706
8. Dierks T., Linden D.E.J., Hertel A., Gunther T., Lanfermann H., Niesen A., Frolich L., Zanella F.E., Hor G., Goebel R., and Maurer K. Multimodal imaging of residual function and compensatory resource allocation in cortical atrophy: a case study of parietal lobe function in a patient with Huntington's disease (vol 84, pg 27, 1998). Psychiatry Research-Neuroimaging 90 (1999) 65-+
9. Feigin A., Fukuda M., Dhawan V., Przedborski S., Jackson-Lewis V., Mentis M.J., Moeller J.R., and Eidelberg D. Metabolic correlates of levodopa response in Parkinson's disease. Neurology 57 (2001) 2083-2088
10. Feigin A., Ghilardi M.F., Huang C.R., Ma Y.L., Carbon M., Guttman M., Paulsen J.S., Ghez C.P., and Eidelberg D. Preclinical Huntington's disease: compensatory brain responses during learning. Ann. Neurol. 59 (2006) 53-59
11. Feigin A., Tang C., Ma Y., Mattis P., Zgaljardic D., Guttman M., Paulsen J.S., Dhawan V., and Eidelberg D. Thalamic metabolism and symptom onset in preclinical Huntington's disease. Brain 130 (2007) 2858-2867
12. Georgiou-Karistianis N., Sritharan A., Farrow M., Cunnington R., Stout J., Bradshaw J., Churchyard A., Brawn T.L., Chua P., Chiu E., Thiruvady D., and Egan G. Increased cortical recruitment in Huntington's disease using a Simon task. Neuropsychologia 45 (2007) 1791-1800
13. Hennenlotter A., Schroeder U., Erhard P., Haslinger B., Stahl R., Weindl A., von Einsiedel H.G., Lange K.W., and Ceballos-Baumann A.O. Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease. Brain 127 (2004) 1446-1453
14. Hilgetag C.C., and Barbas H. Sculpting the BRAIN. Sci. Am. 300 (2009) 66-71
15. Hoshi E., Tremblay L., Feger J., Carras P.L., and Strick P.L. The cerebellum communicates with the basal ganglia. Nat. Neurosci. 8 (2005) 1491-1493
16. Kim J.S., Reading S.A.J., Brashers-Krug T., Calhoun V.D., Ross C.A., and Pearlson G.D. Functional MRI study of a serial reaction time task in Huntington's disease. Psychiatry Research-Neuroimaging 131 (2004) 23-30
17. Leopold D.A. Pre-emptive blood flow. Nature 457 (2009) 387-388
18. Mascalchi M., Lolli F., Della Nave R., Tessa C., Petralli R., Gavazzi C., Politi L.S., Macucci M., Filippi M., and Piacentini S. Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. Radiology 232 (2004) 867-873
19. Paulsen J.S. Functional imaging in Huntington's disease. Exp. Neurol. 216 2 (2009) 272-277
20. Paulsen J.S., Nehl C., and Guttman M. Basal ganglia and movement disorders. In: Rizzo M., and Eslinger P.J. (Eds). Principles and practices and behavioral Neurology and Neuropsychology (2004), WB Saunders, Philadelphia, PA 525-550
21. Paulsen J.S., Zimbelman J.L., Hinton S.C., Langbehn D.R., Leveroni C.L., Benjamin M.L., Reynolds N.C., and Rao S.M. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease. Am. J. Neuroradiol. 25 (2004) 1715-1721
22. Paulsen J.S., Magnotta V.A., Mikos A.E., Paulson H.L., Penziner E., Andreasen N.C., and Nopoulos P.C. Brain structure in preclinical Huntington's disease. Biol. Psychiatry 59 (2006) 57-63
23. Pavese N., Andrews T.C., Brooks D.J., Ho A.K., Rosser A.E., Barker R.A., Robbins T.W., Sahakian B.J., Dunnett S.B., and Piccini P. Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study. Brain 126 (2003) 1127-1135
24. Poldrack R.A., Fletcher P.C., Henson R.N., Worsley K.J., Brett M., and Nichols T.E. Guidelines for reporting an fMRI study. NeuroImage 40 (2008) 409-414
25. Reading S.A.J., Dziorny A.C., Peroutka L.A., Schreiber M., Gourley L.M., Yallapragada V., Rosenblatt A., Margolis R.L., Pekar J.J., Pearlson G.D., Aylward E., Brandt J., Bassett S.S., and Ross C.A. Functional brain changes in presymptomatic Huntington's disease. Ann. Neurol. 55 (2004) 879-883
26. Reading S.A.J., Yassa M.A., Bakker A., Dziorny A.C., Gourley L.M., Yallapragada V., Rosenblatt A., Margolis R.L., Aylward E.H., Brandt J., Mori S., van Zijl P., Bassett S.S., and Ross C.A. Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study. Psychiatry Research-Neuroimaging 140 (2005) 55-62
27. Rosas H.D., Liu A.K., Hersch S., Glessner M., Ferrante R.J., Salat D.H., van der Kouwe A., Jenkins B.G., Dale A.M., and Fischl B. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 58 (2002) 695-701
28. Rosas H.D., Hevelone N.D., Zaleta A.K., Greve D.N., Salat D.H., and Fischl B. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 65 (2005) 745-747
29. Rosas H.D., Tuch D.S., Hevelone N.D., Zaleta A.K., Vangel M., Hersch S.M., and Salat D.H. Diffusion tensor imaging in presymptomatic and early Huntington's disease: selective white matter pathology and its relationship to clinical measures. Mov. Dis. 21 (2006) 1317-1325
30. Saft C., Schuttke A., Beste C., Andrich J., Heindel W., and Pfleiderer B. fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease. Neuropsychologia 46 (2008) 1279-1289
31. Seppi K., Schocke M.F.H., Mair K.J., Esterhammer R., Weirich-Schwaiger H., Utermann B., Egger K., Brenneis C., Granata R., Boesch S., Poewe W., and Wenning G.K. Diffusion-weighted imaging in Huntington's disease. Mov. Dis. 21 (2006) 1043-1047
32. Sirotin Y.B., and Das A. Anticipatory haemodynamic signals in sensory cortex not predicted by local neuronal activity. Nature 457 (2009) U475-U476
33. Sritharan A., Egan G., Johnston L., Horne M., Bradshaw J., Bohanna I., Asadi H., Cunnington R., Churchyard A., Chua P., Farrow M., and Georgiou-Karistianis N. A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease. J. Neurol. Neurosurg. Psychiatry (Electronic publication ahead of print). (2009)
34. Tagamets M.A., and Horwitz B. Interpreting PET and fMRI measures of functional neural activity: the effects of synaptic inhibition on cortical activation in human imaging studies. Brain Res. Bull. 54 (2001) 267-273
35. Thiruvady D.R., Georgiou-Karistianis N., Egan G.F., Ray S., Sritharan A., Farrow M., Churchyard A., Chua P., Bradshaw J.L., Brawn T.L., and Cunnington R. Functional connectivity of the prefrontal cortex in Huntington's disease. J. Neurol. Neurosurg. Psychiatry 78 (2007) 127-133
36. Weeks R.A., Piccini P., Harding A.E., and Brooks D.J. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease. Ann. Neurol. 40 (1996) 49-54
37. Wolf R.C., Vasic N., Schonfeldt-Lecuona C., Landwehrmeyer G.B., and Ecker D. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain 130 (2007) 2845-2857
38. Wolf R.C., Sambataro F., Vasic N., Shonfeldt-Lecuona C., Ecker D., and Landwehrmeyer B. Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Exp. Neurol. 213 (2008) 137-144
39. Wolf R.C., Vasic N., Schonfeldt-Lecuona C., Ecker D., and Landwehrmeyer G.B. Functional imaging of cognitive processes in Huntington's disease and its presymptomatic mutation carriers. Nervenarzt 79 (2008) 408-+
40. Zimbelman J.L., Paulsen J.S., Mikos A., Reynolds N.C., Hoffmann R.G., and Rao S.M. fMRI detection of early neural dysfunction in preclinical Huntington's disease. J. Int. Neuropsychol. Soc. 13 (2007) 758-769